title: Development, characterization, and applications of a novel estrogen receptor beta monoclonal antibody.
abstract: The role of estrogen receptor alpha (ERα) in breast cancer has been studied extensively, and its protein expression is prognostic and a primary determinant of endocrine sensitivity. However, much less is known about the role of ERβ and its relevance remains unclear due to the publication of conflicting reports. Here, we provide evidence that much of this controversy may be explained by variability in antibody sensitivity and specificity and describe the development, characterization, and potential applications of a novel monoclonal antibody targeting full-length human ERβ and its splice variant forms. Specifically, we demonstrate that a number of commercially available ERβ antibodies are insensitive for ERβ and exhibit significant cross-reaction with ERα. However, our newly developed MC10 ERβ antibody is shown to be highly specific and sensitive for detection of full-length ERβ and its variant forms. Strong and variable staining patterns for endogenous levels of ERβ protein were detected in normal human tissues and breast tumors using the MC10 antibody. Importantly, ERβ was shown to be expressed in a limited cohort of both ERα positive and ERα negative breast tumors. Taken together, these data demonstrate that the use of poorly validated ERβ antibodies is likely to explain much of the controversy in the field with regard to the biological relevance of ERβ in breast cancer. The use of the MC10 antibody, in combination with highly specific antibodies targeting only full-length ERβ, is likely to provide additional discriminatory features in breast cancers that may be useful in predicting response to therapy.
authors.affiliation: Department of Biochemistry and Molecular Biology, Mayo Clinic, 200 1st Street SW, Rochester, Minnesota 55905, USA.
authors.forename: Xianglin
authors.initials: X
authors.lastname: Wu
authors.forename: Malayannan
authors.initials: M
authors.lastname: Subramaniam
authors.forename: Vivian
authors.initials: V
authors.lastname: Negron
authors.forename: Muzaffer
authors.initials: M
authors.lastname: Cicek
authors.forename: Carol
authors.initials: C
authors.lastname: Reynolds
authors.forename: Wilma L
authors.initials: WL
authors.lastname: Lingle
authors.forename: Matthew P
authors.initials: MP
authors.lastname: Goetz
authors.forename: James N
authors.initials: JN
authors.lastname: Ingle
authors.forename: Thomas C
authors.initials: TC
authors.lastname: Spelsberg
authors.forename: John R
authors.initials: JR
authors.lastname: Hawse
mesh_terms: D000818:Animals; D058846:Antibodies, Monoclonal, Murine-Derived / Q000096:biosynthesis*; D000918:Antibody Specificity; D014408:Biomarkers, Tumor / Q000276:immunology* / Q000378:metabolism; D001940:Breast / Q000378:metabolism; D001943:Breast Neoplasms / Q000175:diagnosis / Q000378:metabolism* / Q000473:pathology; D002460:Cell Line; D047629:Estrogen Receptor beta / Q000276:immunology* / Q000378:metabolism; D005260:Female; D006801:Humans; D008297:Male; D051379:Mice; D009928:Organ Specificity; D011467:Prostate / Q000378:metabolism; D020033:Protein Isoforms / Q000276:immunology / Q000378:metabolism; D013737:Testis / Q000378:metabolism
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D014408:Biomarkers, Tumor; D047629:Estrogen Receptor beta; D020033:Protein Isoforms
references.citation: J Clin Endocrinol Metab. 2004 Jan;89(1):375-83
references.pmid: 14715875
references.citation: FEBS Lett. 2002 Jul 31;524(1-3):1-5
references.pmid: 12135731
references.citation: Endocr Relat Cancer. 2004 Sep;11(3):537-51
references.pmid: 15369453
references.citation: Am J Surg Pathol. 2003 Dec;27(12):1502-12
references.pmid: 14657709
references.citation: Cancer Res. 2003 May 15;63(10):2434-9
references.pmid: 12750263
references.citation: Breast Cancer Res. 2008;10(5):R74
references.pmid: 18771580
references.citation: CA Cancer J Clin. 2011 Jul-Aug;61(4):212-36
references.pmid: 21685461
references.citation: Br J Cancer. 2002 Dec 2;87(12):1411-6
references.pmid: 12454770
references.citation: Endocrinology. 2001 Sep;142(9):4120-30
references.pmid: 11517191
references.citation: Breast Cancer Res Treat. 2003 Jul;80(1):79-85
references.pmid: 12889601
references.citation: Endocrine. 2005 Aug;27(3):227-38
references.pmid: 16230778
references.citation: N Engl J Med. 1998 Nov 26;339(22):1609-18
references.pmid: 9828250
references.citation: J Pathol. 2002 Dec;198(4):450-7
references.pmid: 12434414
references.citation: Cancer Lett. 2001 Feb 26;163(2):207-12
references.pmid: 11165756
references.citation: Clin Cancer Res. 2005 Oct 15;11(20):7579-85
references.pmid: 16243834
references.citation: Proc Natl Acad Sci U S A. 2004 Feb 10;101(6):1566-71
references.pmid: 14745018
references.citation: Cell. 1989 Nov 3;59(3):477-87
references.pmid: 2805068
references.citation: Jpn J Clin Oncol. 2007 Nov;37(11):820-8
references.pmid: 17932113
references.citation: Cancer Res. 2001 Mar 15;61(6):2537-41
references.pmid: 11289127
references.citation: Br J Cancer. 2001 Apr 20;84(8):1095-8
references.pmid: 11308260
references.citation: J Cell Biochem. 2003 Oct 1;90(2):315-26
references.pmid: 14505348
references.citation: Cancer Res. 2004 Jan 1;64(1):423-8
references.pmid: 14729654
references.citation: Clin Cancer Res. 2007 Apr 1;13(7):1987-94
references.pmid: 17404078
references.citation: Hum Pathol. 2001 Jan;32(1):113-8
references.pmid: 11172304
references.citation: Mol Endocrinol. 2008 Jul;22(7):1579-95
references.pmid: 18483178
references.citation: FEBS Lett. 1996 Aug 19;392(1):49-53
references.pmid: 8769313
references.citation: Br J Cancer. 2006 May 8;94(9):1333-8
references.pmid: 16622466
references.citation: Br J Cancer. 2002 Jan 21;86(2):250-6
references.pmid: 11870515
references.citation: Br J Cancer. 2006 Sep 4;95(5):616-26
references.pmid: 16880783
references.citation: Cell Regul. 1990 Feb;1(3):291-9
references.pmid: 2100202
references.citation: J Cell Biochem. 2007 Aug 1;101(5):1125-47
references.pmid: 17520659
references.citation: Breast Cancer Res Treat. 2008 May;109(2):241-50
references.pmid: 17638070
references.citation: Cancer Chemother Pharmacol. 2003 Jul;52 Suppl 1:S34-8
references.pmid: 12819932
references.citation: J Clin Oncol. 2008 Aug 1;26(22):3727-34
references.pmid: 18669459
references.citation: J Pathol. 2003 Oct;201(2):213-20
references.pmid: 14517838
references.citation: Br J Cancer. 2004 Nov 1;91(9):1687-93
references.pmid: 15477868
references.citation: Jpn J Cancer Res. 2001 Oct;92(10):1057-61
references.pmid: 11676856
references.citation: Cancer Res. 1999 Mar 15;59(6):1175-9
references.pmid: 10096542
references.citation: Breast Cancer Res. 2011 Mar 10;13(2):R27
references.pmid: 21392396
references.citation: Pathol Int. 2006 Aug;56(8):423-7
references.pmid: 16872435
references.citation: Biochem Biophys Res Commun. 1998 Jun 9;247(1):75-8
references.pmid: 9636657
references.citation: Clin Cancer Res. 2004 Nov 15;10(22):7490-9
references.pmid: 15569979
references.citation: Proc Natl Acad Sci U S A. 2001 Dec 18;98(26):15197-202
references.pmid: 11734621
references.citation: Breast Cancer Res Treat. 2011 Jun;127(2):417-27
references.pmid: 20623183
references.citation: Cancer Res. 1999 Feb 1;59(3):525-8
references.pmid: 9973193
references.citation: Toxicol Sci. 2008 Oct;105(2):303-11
references.pmid: 18644836
references.citation: Int J Cancer. 2000 Dec 1;88(5):733-6
references.pmid: 11072241
references.citation: Br J Cancer. 2004 Nov 1;91(9):1694-702
references.pmid: 15477865
references.citation: Clin Cancer Res. 2004 Sep 1;10(17):5769-76
references.pmid: 15355905
references.citation: J Clin Pathol. 2004 May;57(5):523-8
references.pmid: 15113861
references.citation: Clin Cancer Res. 2008 Aug 15;14(16):5228-35
references.pmid: 18698041
references.citation: Eur J Surg Oncol. 2004 Dec;30(10):1043-50
references.pmid: 15522549
references.citation: Cancer Res. 1998 Aug 1;58(15):3197-201
references.pmid: 9699641
references.citation: Oncology. 2010;79(1-2):55-61
references.pmid: 21071990
references.citation: J Biol Chem. 2006 Sep 29;281(39):28596-604
references.pmid: 16873370
references.citation: Cancer Res. 1999 Nov 1;59(21):5421-4
references.pmid: 10554009
references.citation: Oncogene. 2003 Oct 23;22(48):7600-6
references.pmid: 14576822
references.citation: Am J Pathol. 2000 Jan;156(1):29-35
references.pmid: 10623650